Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06626243
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-01
Brief Title:
Analysis of RATS VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An International Multicenter Retrospective Analysis of RATS VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMMUNORATS
Brief Summary:
The study is a retrospective observational study The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic VATS and open approach after receiving neoadjuvant chemo-immunotherapy
There are no risks for the patients as this is a retrospective data collection
There are no risks for the patients as this is a retrospective data collection
Detailed Description:
The use of neoadjuvant chemo-immunotherapy for the treatment of non-small cell lung cancer NSCLC is increasing However there is limited research comparing the feasibility and oncologic efficacy of robot-assisted thoracoscopic surgery RATS video-assisted thoracoscopic surgery VATS and open lung resection in patients already treated with neoadjuvant chemo-immunotherapy This study aims to evaluate the benefits of RATS compared to VATS and open surgery in terms of short-term outcomes for patients with NSCLC undergoing neoadjuvant chemo-immunotherapy
All adult patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection from 01-01-2016 to 31-03-2024 by robotic VATS and open approach after receiving neoadjuvant chemo-immunotherapy will be included
Patients are divided into three groups robotic lung resection video-assisted thoracoscopic VATS lung resection open lung resection
All adult patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection from 01-01-2016 to 31-03-2024 by robotic VATS and open approach after receiving neoadjuvant chemo-immunotherapy will be included
Patients are divided into three groups robotic lung resection video-assisted thoracoscopic VATS lung resection open lung resection
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None